Department of Endocrinology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, China.
Front Endocrinol (Lausanne). 2022 Aug 25;13:959477. doi: 10.3389/fendo.2022.959477. eCollection 2022.
The aim of this study was to analyze the percentages of T helper 17 cells (Th17s) and T regulatory cells (Tregs) in autoimmune Hashimoto's thyroiditis (HT), and the expression of the checkpoint molecules programmed death receptor 1/programmed death ligand 1 (PD-1/PD-L1) on these cells.
This is a case-control study involving 53 initially diagnosed HT patients (HT group) and 21 normal controls (NC group). The peripheral blood mononuclear cells from the individuals of the two groups were isolated and restimulated ; the percentage of Th17s, Tregs, PD-1 Th17s, PD-L1 Th17s, PD-1 Tregs, and PD-L1 Tregs was assessed by flow cytometric analysis.
(1) The percentage of Th17s in the peripheral blood of the HT group was significantly higher than that of the NC group [(6.38 ± 1.32)% versus (3.12 ± 0.66)%; t = 14.110, P < 0.001], while the percentage of peripheral blood Tregs was significantly lower [(3.82 ± 1.48)% versus (5.61 ± 1.60)%; t = -4.599, P < 0.001]. (2) HT patients' Th17s expressed PD-1 at a significantly lower frequency than their counterparts in the NC [(6.46 ± 2.77)% versus (18.51 ± 3.96)%; t = -14.842, P < 0.001], while no difference was observed for PD-L1 between the two groups. (3) In contrast, both PD-1 and PD-L1 were expressed at significantly higher frequency on HT patients' Tregs than on NC [respectively: (17.01 ± 3.04)% versus (10.23 ± 2.77)%; t = 8.850, P < 0.001 for PD-1; (16.60 ± 9.58)% versus (11.36 ± 10.14)%; t = 2.089, P < 0.005, for PD-L1].
(1) The increased percentage of Th17s and decreased percentage of PD-1 Th17s in the HT group suggest that a loss of control on Th17 activity through the checkpoint inhibitory axis PD-1/PD-L1 may participate in disease pathogenesis. (2) While the decreased percentage of Tregs in HT patients may explain a lack of regulatory functions able to prevent the autoimmune destruction of the thyroid, the significance of the increased frequency of Tregs expressing PD-1 and PD-L1, previously reported to boost Tregs differentiation, remains to be established. Elucidating this apparent contradiction may reveal important mechanisms underlying HT pathogenesis.
本研究旨在分析辅助性 T 细胞 17 型(Th17)和调节性 T 细胞(Tregs)在自身免疫性桥本甲状腺炎(HT)中的百分比,以及这些细胞上程序性死亡受体 1/程序性死亡配体 1(PD-1/PD-L1)检查点分子的表达。
这是一项病例对照研究,纳入了 53 例初诊 HT 患者(HT 组)和 21 例正常对照者(NC 组)。分离两组个体的外周血单个核细胞,并进行再刺激;通过流式细胞术分析评估 Th17、Tregs、PD-1 Th17、PD-L1 Th17、PD-1 Tregs 和 PD-L1 Tregs 的百分比。
(1)HT 组外周血 Th17 百分比明显高于 NC 组[(6.38±1.32)%比(3.12±0.66)%;t=14.110,P<0.001],而外周血 Tregs 百分比明显低于 NC 组[(3.82±1.48)%比(5.61±1.60)%;t=-4.599,P<0.001]。(2)HT 患者 Th17 表达 PD-1 的频率明显低于 NC 组[(6.46±2.77)%比(18.51±3.96)%;t=-14.842,P<0.001],而两组 PD-L1 无差异。(3)相反,HT 患者 Tregs 表达 PD-1 和 PD-L1 的频率明显高于 NC 组[分别为:(17.01±3.04)%比(10.23±2.77)%;t=8.850,P<0.001 为 PD-1;(16.60±9.58)%比(11.36±10.14)%;t=2.089,P<0.005,为 PD-L1]。
(1)HT 组 Th17 百分比增加和 PD-1 Th17 百分比降低提示,通过 PD-1/PD-L1 检查点抑制轴对 Th17 活性的失控可能参与了疾病发病机制。(2)HT 患者 Tregs 百分比降低可能解释了缺乏能够防止甲状腺自身免疫破坏的调节功能,但 Tregs 表达 PD-1 和 PD-L1 的频率增加的意义(此前报道可促进 Tregs 分化)仍有待确定。阐明这种明显的矛盾可能揭示了 HT 发病机制的重要机制。